According to an InsideHealthPolicy report, some experts believe the Food and Drug Administration (FDA) should keep away from drug pricing and let the market have the final say on prices.
While the agency has mostly stayed out of the pricing arena, it has been ramping up its participation in discussions on value.
To read the full report, click here.
